Lv41
670 积分 2021-01-04 加入
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
3小时前
已完结
The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review
5天前
已完结
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
8天前
已完结
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
9天前
已完结
Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia
2个月前
已完结
Targeting DKK1 to Remodel the Tumor Microenvironment and Enhance Immune Checkpoint Blockade Therapy
2个月前
已完结
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer
2个月前
已完结
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
2个月前
已完结
皖公网安备34019202002308
